China Innovation Investment Limited (1217) AI Stock Analysis

• Market Cap: HK$166.42M
• Dividend Yield: N/A
• Average Volume (3M): 29.68M
• Price to Earnings (P/E): 8.1
• Beta (1Y): 1.07
• Revenue Growth: 38.96%
• EPS Growth: 700.00%
• Country: HK
• Employees: 16
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): <0.01
• Shares Outstanding: 12,801,579,000
• 10 Day Avg. Volume: 57,745,200
• 30 Day Avg. Volume: 29,677,520
• PEG Ratio: 0.26
• Price to Book (P/B): 0.24
• Price to Sales (P/S): 6.33
• P/FCF Ratio: 0.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 57 Neutral
• Price Target: HK$0.01 ▲(30.00% Upside)

The overall stock score is driven by a strong balance sheet and reasonable valuation. However, concerns about cash flow stability and neutral technical indicators moderate the score. The lack of earnings call data and corporate events limits additional insights.

Positive Factors

Strong balance sheet / low leverage

A high equity ratio (98.9%) and negligible debt give the firm durable financial flexibility to support portfolio companies, pursue opportunistic investments, and withstand market stress. Low leverage reduces solvency risk and limits financing cost pressure over the medium term.

Robust recent revenue and margins

The 2024 revenue surge (549.5%) alongside a 100% gross margin and 24.7% net margin indicates the firm can realize high-return investments and convert gains into profit. Such profitable outcomes support reinvestment, performance fees, and longer-term earnings sustainability when repeatable.

Diversified investment model and partnerships

A diversified mandate across technology, healthcare and consumer sectors plus strategic alliances provides multiple structural revenue streams (capital gains, dividends, management and performance fees). Diversification and partnerships improve deal flow and reduce concentration risk over time.

Negative Factors

Weak cash flow generation

The reported absence of operating, investing, and financing cash flows in 2024 signals persistent cash conversion problems. Weak cash generation constrains the firm's ability to fund operations or follow-on investments internally, may force external financing or asset sales, and raises liquidity risk.

Historical revenue and earnings volatility

Material historical volatility in revenue and net income, including prior-year losses, implies earnings unpredictability. For an investment vehicle, volatile realizations complicate capital planning, fundraising and steady fee income, increasing execution and investor confidence risk over the medium term.

Low return on equity

A 0.9% ROE in 2024 indicates limited effectiveness deploying shareholder capital into profitable returns. With a large equity base and low ROE, the firm may struggle to generate sustained shareholder value absent better deal selection, operational improvements at portfolio firms, or more efficient capital deployment.

China Innovation Investment Limited Business Overview & Revenue Model

Company Description

China Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People's Republic of China. It also engages in transactions comprising options and futures that are traded on recognized securities or futures exchanges and for the purpose of hedging. The company invests in information technology, telecommunications, manufacturing, service, property, infrastructure, life science, and environmental sectors. China Innovation Investment Limited, formerly nown as Sino Technology Investments Company Limited, was incorporated in 2002 and is based in Sheung Wan, Hong Kong.

How the Company Makes Money

China Innovation Investment Limited generates revenue through a diversified investment portfolio, focusing on equity stakes in high-potential companies within innovative sectors. Its revenue model primarily includes capital appreciation from its investments, as well as potential dividends received from portfolio companies. The company may also earn management fees from funds it manages and performance fees based on the returns generated for its investors. Significant partnerships with other investment firms and strategic alliances in targeted industries contribute to its earnings by providing access to additional resources and opportunities for collaboration.

China Innovation Investment Limited Financial Statement Overview

Summary

The company has shown strong revenue growth and profit margins in 2024, but historical volatility and poor cash flow management raise concerns about sustainability. The balance sheet is robust with low leverage, but the lack of cash flow stability is a significant risk.

Income Statement

The company has shown significant revenue growth from 2023 to 2024, with a 549.5% increase. Gross profit margin is strong at 100%, indicating all revenue is contributing to profit. However, the historical volatility in revenue and net income, especially losses in 2021, raises concerns about stability. The net profit margin of 24.7% in 2024 is positive, but past inconsistencies impact the score.

Balance Sheet

The balance sheet is strong with a high equity ratio of 98.9% in 2024, indicating low financial leverage and a solid financial structure. The debt-to-equity ratio is minimal at 0.3%, reflecting low risk from debt obligations. The return on equity for 2024 is 0.9%, suggesting moderate efficiency in utilizing shareholder equity to generate profits.

Cash Flow

The cash flow statement shows a concerning lack of operating, investing, and financing cash flows in 2024, indicating potential issues with cash management or reporting. The absence of free cash flow growth and a historical pattern of negative cash flows highlight risks in liquidity and operational efficiency.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	39.24M	20.26M	3.12M	34.38M	-26.73M	-3.64M
Gross Profit	39.24M	20.26M	9.53M	12.16M	-27.62M	-4.55M
EBITDA	19.70M	5.91M	3.24M	6.64M	-32.94M	-9.03M
Net Income	19.97M	5.00M	2.19M	5.76M	-34.01M	-9.81M
Balance Sheet
Total Assets	616.73M	548.58M	550.22M	564.03M	612.68M	656.35M
Cash, Cash Equivalents and Short-Term Investments	323.35M	299.84M	177.96M	137.63M	156.54M	225.14M
Total Debt	934.00K	1.38M	2.23M	475.00K	1.39M	2.26M
Total Liabilities	50.95M	5.87M	2.55M	770.00K	1.68M	2.60M
Stockholders Equity	565.78M	542.71M	547.67M	563.26M	611.00M	653.75M
Cash Flow
Free Cash Flow	9.13M	178.84M	28.56M	-15.37M	-19.35M	-1.77M
Operating Cash Flow	9.13M	178.84M	28.62M	-14.95M	-19.35M	-1.77M
Investing Cash Flow	-8.56M	-4.97M	6.18M	9.14M	16.79M	6.78M
Financing Cash Flow	-880.00K	-854.00K	-883.00K	-915.00K	-871.00K	-894.00K

China Innovation Investment Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.42 is Neutral, neither overbought nor oversold. The STOCH value of -100.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1217.

China Innovation Investment Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
0768	66 Neutral	HK$54.68M	4.89	12.66%	―	43.59%	104.35%
1217	57 Neutral	HK$166.42M	8.13	3.56%	―	38.96%	700.00%
0310	50 Neutral	HK$124.23M	-2.00	―	―	―	―
0080	46 Neutral	HK$722.54M	-27.48	-30.83%	―	―	―
2312	45 Neutral	HK$462.07M	45.08	11.27%	―	99.09%	―
0033	41 Neutral	HK$223.30M	-14.13	―	―	9.10%	66.31%

China Innovation Investment Limited Corporate Events

China Innovation Investment Reports Unaudited NAV Per Share of HK$0.047

China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.047 as of 31 December 2025. The disclosure provides investors with an updated snapshot of the company’s balance-sheet strength and per-share asset backing, information that can influence valuation assessments and inform shareholder expectations regarding the firm’s financial position going into 2026.

The most recent analyst rating on (HK:1217) stock is a Buy with a HK$0.02 price target. To see the full list of analyst forecasts on China Innovation Investment Limited stock, see the HK:1217 Stock Forecast page.

China Innovation Investment Limited Reports Net Asset Value

China Innovation Investment Limited announced that as of November 30, 2025, its unaudited net asset value per share was approximately HK$ 0.047. This update provides stakeholders with an insight into the company’s financial standing, potentially impacting investor perceptions and market positioning.

The most recent analyst rating on (HK:1217) stock is a Hold with a HK$0.02 price target. To see the full list of analyst forecasts on China Innovation Investment Limited stock, see the HK:1217 Stock Forecast page.

China Innovation Partners with Jiangsu Lizhuo for AI in Agriculture

China Innovation Investment Limited has entered into a strategic investment framework agreement with Jiangsu Lizhuo Information Technology Co., Ltd. to promote the application of artificial intelligence in agriculture. This collaboration aims to leverage Jiangsu Lizhuo’s technological strengths to expand its market presence and develop integrated AI solutions for agriculture, with plans for nationwide and overseas expansion, particularly in Southeast Asia and the Belt and Road regions.

China Innovation Investment Limited Announces Partial Offer for Elife Holdings Shares

China Innovation Investment Limited has announced the despatch of an offer document related to a voluntary conditional cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited. This move is part of a series of announcements made by the company throughout 2025. The offer document, which includes terms and conditions of the partial offer, has been sent to shareholders and is available on the Stock Exchange’s website. The timetable for the offer is outlined, with key dates for acceptance and announcement of results specified, indicating a strategic move to potentially increase its stake in Elife Holdings Limited.